VX-702
产品名称:VX-702
产品描述:
产品描述 | VX-702 is a highly specific p38α MAPK inhibitor, 14-fold higher selectivity for the p38α than p38β. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA). |
靶点活性 | p38α:4 nM-20 nM |
体外活性 | 每天两次VX-702(0.1 mg/kg)处理与甲胺喋呤(0.1 mg/kg)处理效果接近.此外,每天两次VX-702(5 mg/kg)处理与每天一次氢化泼尼松(10 mg/kg)处理效果类似.与对照组和用5 mg/kg VX-702处理实验组相比,50 mg/kg实验组的MI/AAR比率显著降低.VX-702半衰期为16-20 h,半数清除剂量3.75 L,分布容积为73 L/kg. VX-702对p38 MAPK活性具有选择性抑制作用,但不影响ERKs和JNKs. |
体内活性 | VX-702不影响p38 MAPK兴奋剂诱导的血小板聚集。用VX-702(1 μM)处理血小板,可完全或部分抑制由血小板兴奋剂(包括凝血酵素,AYPGKF,SFLLRN,U46619和胶原)诱导的p38活性(IC50:4-20 nM)。VX-702剂量依赖性地抑制IL-6(IC50:59 ng/ml)、IL-1β(IC50:122 ng/ml)和TNFα(IC50:99 ng/ml)的产生。 |
激酶实验 | HDAC enzyme assay in vitro: The deacetylase enzyme assay is based on a homogeneous fluorescence release assay. Purified recombinant HDAC enzymes are incubated with MGCD0103 diluted in various concentrations for 10 minutes in assay buffer [25 mM HEPES (pH 8.0), 137 mM NaCl, 1 mM MgCl2, 2.7 mM KCl] at room temperature. The substrate Boc-Lys(ε-Ac)-AMC is added to the reaction for further incubation at 37 °C. The concentration of the substrate and the incubation time varies for different isotypes of HDAC enzymes. A 20-min trypsin incubation at room temperature allows the release of the fluorophore from the deacetylated substrate. The fluorescent signal is detected by fluorometer at excitation of 360 nm, emission of 470 nm, and cutoff at 435 nm. |
分子量 | 404.3 |
分子式 | C19H12F4N4O2 |
CAS No. | 745833-23-2 |
存储
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
溶解度
Ethanol: <1 mg/mL
H2O: <1 mg/mL
DMSO: 75 mg/mL (185.5 mM)
( < 1 mg/mL refers to the product slightly soluble or insoluble )
联系我们:
邮箱:2519696869@qq.com
QQ: 2519696869
电话:18066853083
微信:18066853083

公司介绍:
西安齐岳生物科技有限公司是集化学科研和定制与一体的高科技化学公司。业务范围包括化学试剂和产品的研发、生产、销售等。涉及产品为通用试剂的分销、非通用试剂的定制与研发,涵盖生物科技、化学品、中间体和化工材料等领域。
主营产品:COF、MOF单体系列:三蝶烯衍生物、金刚烷衍生物、四苯甲烷衍生物、peg、上转换、石墨烯、光电材料、点击化学、凝集素、载玻片、蛋白质交联剂、脂质体、蛋白、多肽、氨基酸、糖化学等。